Clinical trial
Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the…
NCT00139230 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00139230 |
|---|---|
| Title | Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck |
| Official title | TPLF-4, Compressed TPLF for Locally Advanced Squamous Cell Carcinoma |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Massachusetts General Hospital Sanofi Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Squamous Cell Carcinoma, Carcinoma of Head/Neck |
| Intervention type | Drug |
| Interventions | Taxotere, Cisplatin, 5-Fluorouracil, Leucovorin, G-CSF, Ciprofloxacin |
| Enrollment | 30 |
| Start date | Jan 1, 1997 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Aug 31, 2005 |
| Last update posted | Jun 3, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: